Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Capricor Therapeutics (CAPR) Fails to deliver data
Key failure to deliver metrics for Capricor Therapeutics :
- Last SEC data release: 2024-05-31
- Last 15 days FTD volume: $0.25 M
- Last 3 months FTD volume: $2.09 M
- Last year FTD volume: $6.52 M
Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019
Volume in USD (price x number of shares), data since 2019Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.97 M | -19.11% |
| 2023 | $3.67 M | 24.67% |
| 2022 | $2.94 M | -49.93% |
| 2021 | $5.88 M | -88.57% |
| 2020 | $51.49 M | 573.14% |
| 2019 | $7.65 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $36.72 M | $0.59 B | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $0.44 M | $32.24 M | 🇺🇸 USA |
 Cytokinetics
CYTK | $26.6 M | $0.11 B | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.71 M | $3.68 M | 🇺🇸 USA |
 Palatin Technologies PTN | $1.45 M | $2.1 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.04 M | $0.26 M | 🇺🇸 USA |